Live Breaking News & Updates on Industrie Biomediche Insubri

Stay updated with breaking news from Industrie biomediche insubri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TheraVet Reports Its 2022 Half-year Results and Provides an Update on the Development of Its Activities

Regulatory News: TheraVet (ISIN: BE0974387194 ticker: ALVET) (Paris:ALVET) (Brussels:ALVET), a pioneering company in the management of osteoarticular diseases in pets, today announces its financial ....

Walloon Region , Waals Gewest , United States , France General , United Kingdom , Bruxelles Capitale , Arthur Rouill , Martin Hugo Willefert , Industrie Biomediche Insubri , Newcap Belgique , Veterinary Orthopedic Society , World Veterinary Orthopaedic Congress , Financial Communications , Regulatory News , United Kingdom Ireland , General Assembly , Linkedin Facebook Twitter , World Veterinary Orthopaedic , Operating Officer , Corporate Officer , Eve Monfort ,

TheraVet Provides Its 2022 First Half-year Operational Update

TheraVet Provides Its 2022 First Half-year Operational Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , France General , United Kingdom , Bruxelles Capitale , Waals Gewest , Martin Olivier Bricaud , Enrico Bastianelli , Arthur Rouill , Industrie Biomediche Insubri , Ambre Delval , Newcap Belgique , Conference Of The Veterinary Orthopedic Society , World Veterinary Orthopaedic Congress , Financial Communications , Chief Executive Officer , Bone Surgery , Annual Conference , Veterinary Orthopedic Society , Best Poster Presentation Award , Veterinary Instrumentation , Bone Surgery Ready To Use , Osteosarcoma Ready To Use , Key Opinion Leaders , Financial Results , Euronext Growth , Olivier Bricaud ,

TheraVet Reports Full Year 2021 Financial Results and Confirms Its Ambitious Development and Commercial Plans for 2022

Positive safety and efficacy results for BIOCERA-VET (arthrodesis and canine osteosarcoma) and VISCO-VET (canine osteoarthritis) Initiation of the pivotal European multicentric clinical study ....

United States , France General , United Kingdom , Bruxelles Capitale , Waals Gewest , Martin Olivier Bricaud , Enrico Bastianelli , Arthur Rouill , Industrie Biomediche Insubri , Ambre Delval , Newcap Belgique , Financial Communications , Chief Executive Officer , Initial Public Offering , Initial Public , Veterinary Orthopedic Conference , Regulatory Agencies , General Assembly , Linkedin Facebook Twitter , Operating Officer , Corporate Officer , Eve Monfort ,

TheraVet Reports Full Year 2021 Financial Results and Confirms Its Ambitious Development and Commerc

Positive safety and efficacy results for BIOCERA-VET® (arthrodesis and canine osteosarcoma) and VISCO-VET® (canine osteoarthritis)Initiation of the pivotal European multicentric clinical study evaluating VISCO-VET® in canine osteoarthritisCommercialization of BIOCERA-VET® Bone Surgery and BIOCERA-VET® Osteosarcoma i. ....

United States , France General , United Kingdom , Waals Gewest , Bruxelles Capitale , Martin Olivier Bricaud , Enrico Bastianelli , Arthur Rouill , Industrie Biomediche Insubri , Ambre Delval , Newcap Belgique , Financial Communications , Bone Surgery , Regulatory News , Chief Executive Officer , Initial Public Offering , Initial Public , Veterinary Orthopedic Conference , Regulatory Agencies , General Assembly , Olivier Bricaud ,